Market Place
Sourcing Support
All News #Library
Biotech
Coave Therapeutics Introduces OneAAVTM Capsid At ASGCT 2026
28 Apr 2026 //
GLOBENEWSWIRE
Coave Therapeutics Launches Gene Therapy Program For RVD Disease
14 Nov 2025 //
GLOBENEWSWIRE
Coave Therapeutics Shows Novel Suprachoroidal Capsid Superiority
07 Oct 2025 //
GLOBENEWSWIRE
Coave Therapeutics Launches coAAV-CSF-01 for CNS Diseases
09 May 2025 //
GLOBENEWSWIRE
Coave Therapeutics Expands into US with Romain Pettenaro as VP of BD
23 Apr 2025 //
GLOBENEWSWIRE
Coave Therapeutics to Attend Upcoming Conferences
09 Apr 2025 //
GLOBENEWSWIRE
Coave Secures €32M Series A For Next-Gen Genetic Medicines
09 Jan 2025 //
GLOBENEWSWIRE
Coave Showcases Breakthrough In AAV Vectors At ESGCT 2024
22 Oct 2024 //
GLOBENEWSWIRE
Coave Therapeutics to Present ALIGATER™ Platform Data at Conferences
24 Sep 2024 //
GLOBENEWSWIRE
EyeDNA 24-Month Gene Therapy Data In Retinitis Pigmentosa At ARVO
07 May 2024 //
GLOBENEWSWIRE
eyeDNA To Present HORA-PDE6b Data at ARVO 2024
25 Apr 2024 //
GLOBENEWSWIRE
Coave Receives Grant from the ALS Association to Advance its CTx-TFEB Program
29 Feb 2024 //
GLOBENEWSWIRE
Coave announces Positive 12-months Data from Phase I/II Trial of CTx-PDE6b
31 May 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.